Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tranylcypromine in recurrent brief depression: two case reports

R T Joffe1

  • 1Mood Disorders Program, McMaster University Medical Centre, Hamilton, ON, Canada.

International Clinical Psychopharmacology
|December 1, 1996
PubMed
Summary

Tranylcypromine, a monoamine oxidase inhibitor, showed therapeutic effects in two patients with recurrent brief depression. This suggests potential efficacy where selective serotonin reuptake inhibitors fail.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The pharmacological management of depression.

Canadian family physician Medecin de famille canadien·2011
Same author

One-year outcome with antidepressant--treatment of bipolar depression.

Acta psychiatrica Scandinavica·2005
Same author

Does a combination regimen of thyroxine (T4) and 3,5,3'-triiodothyronine improve depressive symptoms better than T4 alone in patients with hypothyroidism? Results of a double-blind, randomized, controlled trial.

The Journal of clinical endocrinology and metabolism·2003
Same author

Induction of mania and cycle acceleration in bipolar disorder: effect of different classes of antidepressant.

Acta psychiatrica Scandinavica·2002
Same author

Recollection memory deficits in patients with major depressive disorder predicted by past depressions but not current mood state or treatment status.

Psychological medicine·2002
Same author

Backward masking task performance in stable, euthymic out-patients with bipolar disorder.

Psychological medicine·2001

Area of Science:

  • Psychiatry
  • Neuroscience
  • Pharmacology

Background:

  • Recurrent brief depression (RBD) is a challenging subtype of mood disorder.
  • Conventional antidepressants, including selective serotonin reuptake inhibitors (SSRIs), often show limited efficacy in RBD.
  • Understanding treatment responses in specific depression subtypes is crucial for effective patient care.

Observation:

  • Two patients with diagnosed recurrent brief depression were treated.
  • The patients received tranylcypromine, a first-generation monoamine oxidase inhibitor (MAOI).
  • A notable therapeutic response was observed in both cases.

Findings:

  • Tranylcypromine demonstrated significant efficacy in treating recurrent brief depression in these two cases.
  • This contrasts with the reported lack of response to SSRIs in similar patient profiles.

Related Experiment Videos

  • MAOIs may represent a viable treatment option for specific depression subtypes unresponsive to SSRIs.

    • Implications:

    • These findings suggest that first-generation MAOIs like tranylcypromine could be effective for treating recurrent brief depression.
    • Further research is warranted to explore the efficacy and safety of MAOIs in larger cohorts of patients with RBD.
    • This could lead to revised treatment guidelines for depression subtypes that are refractory to SSRIs.